Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    21208106 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS)
Condition: Non-Constipation Irritable Bowel Syndrome
Interventions: Drug: Rifaximin;   Drug: Placebo
2 Completed
Has Results
Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS)
Condition: Non-Constipation Irritable Bowel Syndrome
Interventions: Drug: Rifaximin;   Drug: Placebo

Indicates status has not been verified in more than two years